<p>Effect size is defined by the relative risk (RR, on the x-axis) of disease comparing individuals in the top and bottom quartiles of the “usual” metabolite level. The top axis shows the naïve relative risk that would be observed in the study without adjusting for measurement error. Each figure varies one parameter: sample size, α-level, or the number of samples/individual. (A) presents power curves according to different sample size (n of 500, 1,000 and 5,000) under a Bonferroni-adjusted α-levels (0.05/539); (B) presents power curves with different α-levels in a case-control study of 1,000 individuals; (C) presents power curves in a case-control study of 1,000 individuals, with different number of distinct urinary samples (1, 3, and 10, α...
<p>Number of diseased subjects recruited in control sample (A); Ratio of upper and lower bound of 95...
<p>The size of the circles represents the relative difference in population attributable risk percen...
(A) Main demographic and clinical characteristics of the enrolled subjects (right panel); for each g...
a<p>Each row list the percentage of metabolites with an estimated parameter (ICC, and ) exceeding t...
<p>Box plots indicate the distribution of magnitudes of peak intensity levels of key metabolic pheno...
<p>Left panel: Power versus relative risk ratio (RRR) for different sample sizes, minor allele frequ...
<p>The color of the line represents the proportion of total variance capture by the risk score, with...
Many epidemiologists conducting case-control studies choose to dichotomize their exposure data to ma...
<p>Sample sizes (number of study participants) required to detect adverse effects of medicines in tr...
<p>Box plots show the distributions of: a) grey matter volume: F (1, 74) = 13.78, <i>p</i> = 0.0004,...
<p>(A) Box plots from Urine-0h (B) Box plots from Urine-24h samples. Boxes denote interquartile rang...
The importance of the area under the normal curve (AUC) as a measure of the effect size (ES) in appl...
<p>The power of curves as a function of sample sizes of 11 statistics for collectively testing the a...
<p>The curves in (<b>A</b>) from the bottom to the top of the graph are in the order of min effect s...
Object: Cohort studies in pharmacoepidemiology can result in a unique type of study where subjects h...
<p>Number of diseased subjects recruited in control sample (A); Ratio of upper and lower bound of 95...
<p>The size of the circles represents the relative difference in population attributable risk percen...
(A) Main demographic and clinical characteristics of the enrolled subjects (right panel); for each g...
a<p>Each row list the percentage of metabolites with an estimated parameter (ICC, and ) exceeding t...
<p>Box plots indicate the distribution of magnitudes of peak intensity levels of key metabolic pheno...
<p>Left panel: Power versus relative risk ratio (RRR) for different sample sizes, minor allele frequ...
<p>The color of the line represents the proportion of total variance capture by the risk score, with...
Many epidemiologists conducting case-control studies choose to dichotomize their exposure data to ma...
<p>Sample sizes (number of study participants) required to detect adverse effects of medicines in tr...
<p>Box plots show the distributions of: a) grey matter volume: F (1, 74) = 13.78, <i>p</i> = 0.0004,...
<p>(A) Box plots from Urine-0h (B) Box plots from Urine-24h samples. Boxes denote interquartile rang...
The importance of the area under the normal curve (AUC) as a measure of the effect size (ES) in appl...
<p>The power of curves as a function of sample sizes of 11 statistics for collectively testing the a...
<p>The curves in (<b>A</b>) from the bottom to the top of the graph are in the order of min effect s...
Object: Cohort studies in pharmacoepidemiology can result in a unique type of study where subjects h...
<p>Number of diseased subjects recruited in control sample (A); Ratio of upper and lower bound of 95...
<p>The size of the circles represents the relative difference in population attributable risk percen...
(A) Main demographic and clinical characteristics of the enrolled subjects (right panel); for each g...